Overexpression of CLDN1 promotes epithelial–mesenchymal transition, metastasis, resistance to anoikis, and chemotherapy in colon cancer cells through a direct interaction with ephrin type-A receptor 2 tyrosine kinase [42]. Here, CLDN1 is linked to malignant colon neoplasm.